Literature DB >> 10094172

Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis.

O Lortholary1, F Deniel, P Boudon, M P Le Pennec, M Mathieu, M Soilleux, C Le Pendeven, P Loiseau, V Vincent, D Valeyre.   

Abstract

SETTING: Department of Seine-Saint-Denis, France.
OBJECTIVE: To compare the presentation and outcome of Mycobacterium kansasii infections according to human immunodeficiency virus (HIV) status.
DESIGN: Retrospective analysis of all the medical charts of adults meeting the diagnostic criteria of the American Thoracic Society for M. kansasii infection between 1991 and 1995.
RESULTS: Between 1991 and 1995, 35 cases (23 HIV-[6%] and 12 HIV+ [34%]) were found, giving an annual incidence of 0.5/100000. The following particularities were common to both groups: 1) frequency and prominence of respiratory and general symptoms, 2) rarity of clinically apparent extra-thoracic involvement, 3) bacteriological confirmation mostly obtained with respiratory tract specimens, 4) favourable bacteriological outcome, and 5) low mortality attributable to the mycobacterial infection. The most striking differences concerned chest radiography: HIV- patients had apical cavitated and nodular lesions, while HIV+ patients exhibited a variety of other patterns, including alveolar infiltrates, miliary lesions and/or thoracic lymphadenopathy.
CONCLUSION: Apart from pulmonary radiographic differences, presentation and short-term outcome of M. kansasii infections were similar in HIV+ and HIV-patients.

Entities:  

Mesh:

Year:  1999        PMID: 10094172

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  Molecular analysis of Mycobacterium kansasii isolates from the United States.

Authors:  Yansheng Zhang; Linda B Mann; Rebecca W Wilson; Barbara A Brown-Elliott; Véronique Vincent; Yoshitsugu Iinuma; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Nontuberculous mycobacteria, zambia.

Authors:  Patricia C A M Buijtels; Marianne A B van-der-Sande; Cas S de-Graaff; Shelagh Parkinson; Henri A Verbrugh; Pieter L C Petit; Dick van-Soolingen
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.